Showing results (1-10 of 330) with videos related to
Sort By:
Pageof 33
Current Opinion in Infectious Diseases|July 3, 2009
New developments in Plasmodium vivax malaria: severe disease and the rise of chloroquine resistanceRic N Price, Nicholas M Douglas, Nicholas M AnsteyCurrent Opinion in Infectious Diseases|October 12, 2011
Plasmodium vivax treatments: what are we looking for?Ric N Price, Nicholas M Douglas, Nicholas M Anstey, et al.Advances in Parasitology|December 4, 2012
Plasmodium vivax: clinical spectrum, risk factors and pathogenesisNicholas M Anstey, Nicholas M Douglas, Jeanne R Poespoprodjo, et al.The Lancet. Infectious Diseases|June 1, 2010
Artemisinin combination therapy for vivax malariaNicholas M Douglas, Nicholas M Anstey, Brian J Angus, et al.Advances in Parasitology|December 4, 2012
Chemotherapeutic strategies for reducing transmission of Plasmodium vivax malariaNicholas M Douglas, George K John, Lorenz von Seidlein, et al.The American Journal of Tropical Medicine and Hygiene|December 12, 2022
Primaquine-induced Severe Hemolysis in the Absence of Concomitant Malaria: Effects on G6PD Activity and Renal FunctionNicholas M Douglas, Kim A Piera, Angela Rumaseb, et al.Malaria Journal|December 19, 2025
Enhancing unique identification of patients with malaria using biometric fingerprinting in Papua, IndonesiaLiony Fransisca, Enny Kenangalem, Reynold Rizal Ubra, et al.Plos One|January 30, 2020
Malaria-related hospitalization during childhood in Papua, Indonesia: A retrospective cohort studyNicholas M Douglas, Enny Kenangalem, Afdhal Hasanuddin, et al.Malaria Journal|August 21, 2012
Primaquine radical cure of Plasmodium vivax: a critical review of the literatureGeorge K John, Nicholas M Douglas, Lorenz von Seidlein, et al.International Journal for Parasitology. Drugs and Drug Resistance|February 18, 2014
Monitoring antimalarial drug resistance: Applying lessons learned from the past in a fast-moving presentCarol Hopkins Sibley, Ric N PricePageof 33